Modern glaucoma treatments can only preserve a patient’s current level of vision, offering no hope of restoration. A new Phase 1 clinical trial is using gene therapy that could turn back the clock on ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before. Earlier this week, Life Biosciences, a biotech company focused on reversing age-related ...

Americans routinely say they relish the ability to work from home or remotely rather than commute to an office. Yet new research suggests that untethering yourself can come at a cost. New research ...

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general malaise. Those symptoms, which typically resolve within days, are the natural ...

Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor inhibition where conventional immunotherapy fails. (Nanowerk Spotlight) ...

A metabolic reset is not a scientific procedure. Instead, it involves various lifestyle and dietary changes that aim to improve a person’s metabolic health and potentially lose body weight. Weight ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...

Across much of America, workers fear their options for remote work are slipping away. But remote work is alive and well, at least for now. Five years into the pandemic workplace revolution, roughly 38 ...

Certain combinations work, like chocolate and peanut butter or Black Sabbath and eardrums. Other combinations don't, like orange juice and toothpaste or remote starters and manual transmissions. Well, ...

A first-in-class antisense oligonucleotide — RES-010 (Resalis Therapeutics, Turin, Italy) — may complement and enhance the efficacy of antiobesity drugs such as GLP-1 receptor agonists (RAs), ...